28 reports

  • RECKITT BENCKISER (US COUGH AND COLD OTC DRUG SALES) - FINANCIAL PERFORMANCE*
  • PFIZER (US OTC COUGH AND COLD MEDICINE SALES) - FINANCIAL PERFORMANCE*

Get well: Seasonal colds will facilitate growth, but prescription drugs will limit demand Abstract Cough & Cold Medicine Manufacturing OTC Cough and cold medicine manufacturers benefited from an increasing number of consumers purchasing over-the-counter (OTC) medications as a form of...

  • Cough And Cold
  • OTC
  • Pharmaceutical
  • United States
  • Demand

The 2019-2024 World Outlook for Combination Cough-Cold-Allergy Medicines ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cough And Cold
  • OTC
  • World
  • Demand

The 2019-2024 Outlook for Combination Cough-Cold-Allergy Medicines in China ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cough And Cold
  • OTC
  • China
  • Demand

The 2019-2024 Outlook for Combination Cough-Cold-Allergy Medicines in the United States ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cough And Cold
  • OTC
  • United States
  • Demand

The 2019-2024 Outlook for Combination Cough-Cold-Allergy Medicines in India ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cough And Cold
  • OTC
  • India
  • Demand

Cough/ Cold Remedies - Market Trends & Insights ##.

  • Cough And Cold
  • OTC
  • United States
  • Demand
  • Market Shares
  • Cough and Cold Medicine
  • Cough and Cold Medicine Export and Market Share (billion

This study focuses on China’s Respiratory Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • Trade
  • Cough and Cold Medicine
  • Cough and Cold Medicine Producers

China’s demand for Respiratory Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • GlaxoSmithKline plc

This influence varies from one industry to another, but also from one period of time to another.

  • Cough And Cold
  • OTC
  • Pharmaceutical
  • World
  • Demand
  • Cough Medicine

The auto exports exceeded over ## million each year.

  • Cough And Cold
  • China
  • Demand
  • Forecast
  • Market Size
  • Sales Per Capita of Select CCA Products and Y-o-Y % Growth of CCA Category 2011-2016
  • What do consumers take when they get sick?

Generally, among flu-related medicines, US consumers spend the most per capita on combination cough, cold and allergy products.

  • Cough And Cold
  • Influenza
  • United States
  • Demand
  • Mondelez International, Inc.

(India) ##.

  • Cough And Cold
  • United States
  • World
  • Demand
  • Market Shares

(India) ##.

  • Cough And Cold
  • Australasia
  • United States
  • World
  • Market Shares

This influence varies from one industry to another, but also from one period of time to another.

  • Cough And Cold
  • OTC
  • Pharmaceutical
  • United States
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Cough And Cold
  • OTC
  • Pharmaceutical
  • China
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Cough And Cold
  • OTC
  • Pharmaceutical
  • India
  • Demand

(USA) ##.

  • Cough And Cold
  • United States
  • World
  • Demand
  • Market Shares

(USA) ##.

  • Cough And Cold
  • China
  • United States
  • Demand
  • Market Shares
  • Allergy, Cough, Cold, and Sinus Products
  • Three: Allergy, Cough, Cold, and Sinus Products

Over the past 38 years the U.S. Rx-to-OTC market has grown into a $7.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide...

  • Cough And Cold
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Jul 13, 2017: WEIFA: Record Second-Quarter Revenues Driven By Pain And Cough & Cold
  • Aqualis Completes Rights Offering Of Shares For US$9 Million

Summary Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions.The company has over the counter (OTC) pharmaceutical market in Norway offering products for pain relief;...

  • Cough And Cold
  • Pharmaceutical
  • Norway
  • M&A
  • Weifa
  • Nasopharyngitis (Common Cold) - Product Development Milestones
  • Mechanism Of Action R&D Progress

Chlorpheniramine is one of the most widely used anti-histamines to manage cough and cold co-symptoms.

  • Cough And Cold
  • United States
  • World
  • Company Sales
  • Product Initiative
  • Clinical Trials
  • Apr 13, 2016: Vernalis Announces Successful Completion of CCP-08 Pivotal Single-Dose Comparative Bioavailability Study

One of the Phase IIa studies was in Cystic Fibrosis patients with statistically significant increases in average forced expiratory volume in one second.

  • Cough And Cold
  • Healthcare
  • Pharmaceutical
  • United States
  • Vernalis plc
  • Vernalis Plc, Major Products and Services
  • Jul 18, 2017: Vernalis: Year-End Trading Update and Notice of Full Year Results

Vernalis Plc (VER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The...

  • Cough And Cold
  • Pharmaceutical
  • United States
  • Company Financials
  • Vernalis plc
  • Nasopharyngitis (Common Cold) - Product Development Milestones
  • Nasopharyngitis (Common Cold)

Chlorpheniramine is one of the most widely used anti-histamines to manage cough and cold co-symptoms.

  • Cough And Cold
  • Respiratory Disease
  • United States
  • World
  • Product Initiative
  • Alfa Intes Enters into Licensing Agreement with Bitop for Ectoin Allergy Nasal Spray
  • Jadran Galenski laboratorij Enters Into Licensing Agreement With Bitop For Ectoin Allergy Nasal Spray

It offers medical devices for dermatology, allergy, cough and cold; airway diseases and dry epithelia applications.

  • Cough And Cold
  • Medical Equipment
  • OTC
  • United States
  • Deals & Alliance
  • LICENSING AGREEMENTS

It offers medical devices for dermatology, allergy, cough and cold; airway diseases and dry epithelia applications.

  • Cough And Cold
  • United States
  • Company
  • Deals & Alliance
  • GlobalData's company
  • Untitled
  • Untitled

Tris Pharma, Inc Company Profile Company Profile is a complete analysis of the company’s operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile, future plans and projects being planned by the company. Current operations, potential segments along...

  • Cough And Cold
  • United States
  • Company
  • Product Initiative
  • Tris Pharma, Inc.
  • Vernalis Plc Overview
  • Vernalis Plc - Company Statement

It targets checkpoint kinase ## (Chk ##).

  • Cough And Cold
  • Therapy
  • United States
  • Company Operations
  • Vernalis plc